Xanthohumol inhibits the extracellular signal regulated kinase (ERK) signalling pathway and suppresses cell growth of lung adenocarcinoma cells

作者: Adrianna Sławińska-Brych , Barbara Zdzisińska , Magdalena Dmoszyńska-Graniczka , Witold Jeleniewicz , Jacek Kurzepa

DOI: 10.1016/J.TOX.2016.06.008

关键词: XanthohumolDownregulation and upregulationCyclin D1Cell biologyCell cycleBiologyCell growthKinaseCancer cellCancer researchMAPK/ERK pathway

摘要: Aberrant activation of the Ras/MEK/ERK signaling pathway has been frequently observed in non-small-cell lung carcinoma (NSCLC) and its important role cancer progression malignant transformation documented. Hence, ERK1/2 kinase cascade becomes a potential molecular target treatment. Xanthohumol (XN, prenylated chalcone derived from hope cones) is known to possess broad spectrum chemopreventive anticancer activities. In our studies, MTT BrdU assays revealed that XN demonstrated greater antiproliferative activity against A549 adenocarcinoma cells than H1563 cell line. We was able suppress activities p90RSK kinases, followed by inhibition phosphorylation CREB protein. Additionally, treatment caused upregulation key cycle regulators p53 p21 as well downregulation cyclin D1. As result, cytotoxic effect attributed arrest at G1 phase induction apoptosis indicated increased caspase-3 activity. Thus, might be promising drug candidate carcinomas.

参考文章(48)
Adrianna Sławińska-Brych, Sylwia Katarzyna Król, Magdalena Dmoszyńska-Graniczka, Barbara Zdzisińska, Andrzej Stepulak, Mariusz Gagoś, Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro. Chemico-Biological Interactions. ,vol. 240, pp. 110- 118 ,(2015) , 10.1016/J.CBI.2015.08.008
Joel S. Britson, Frederick Barton, Justin M. Balko, Esther P. Black, Deregulation of DUSP activity in EGFR-mutant lung cancer cell lines contributes to sustained ERK1/2 signaling Biochemical and Biophysical Research Communications. ,vol. 390, pp. 849- 854 ,(2009) , 10.1016/J.BBRC.2009.10.061
Adriana Albini, Raffaella Dell'Eva, Roberta Vené, Nicoletta Ferrari, Donald R. Buhler, Douglas M. Noonan, Gianfranco Fassina, Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-κB and Akt as targets The FASEB Journal. ,vol. 20, pp. 527- 529 ,(2006) , 10.1096/FJ.05-5128FJE
Michela Festa, Anna Capasso, Cosimo W D’Acunto, Milena Masullo, Adriano G Rossi, Cosimo Pizza, Sonia Piacente, None, Xanthohumol induces apoptosis in human malignant glioblastoma cells by increasing reactive oxygen species and activating MAPK pathways. Journal of Natural Products. ,vol. 74, pp. 2505- 2513 ,(2011) , 10.1021/NP200390X
Martina Pilatova, Lenka Varinska, Pal Perjesi, Marek Sarissky, Ladislav Mirossay, Peter Solar, Alexander Ostro, Jan Mojzis, None, In vitro antiproliferative and antiangiogenic effects of synthetic chalcone analogues. Toxicology in Vitro. ,vol. 24, pp. 1347- 1355 ,(2010) , 10.1016/J.TIV.2010.04.013
Barbara Vanhoecke, Lara Derycke, Veerle Van Marck, Herman Depypere, Denis De Keukeleire, Marc Bracke, Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer International Journal of Cancer. ,vol. 117, pp. 889- 895 ,(2005) , 10.1002/IJC.21249
João R. Araújo, Pedro Gonçalves, Fátima Martel, Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines Nutrition Research. ,vol. 31, pp. 77- 87 ,(2011) , 10.1016/J.NUTRES.2011.01.006
L. Delmulle, T. Vanden Berghe, D. De Keukeleire, P. Vandenabeele, Treatment of PC-3 and DU145 prostate cancer cells by prenylflavonoids from hop (Humulus lupulus L.) induces a caspase-independent form of cell death. Phytotherapy Research. ,vol. 22, pp. 197- 203 ,(2008) , 10.1002/PTR.2286